Detalles de la búsqueda
1.
Biopsy-Guided Pathological Response Assessment in Breast Cancer is Insufficient: Additional Pathology Findings of the MICRA Trial.
Ann Surg Oncol
; 30(8): 4682-4689, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37071235
2.
Minimally Invasive Complete Response Assessment of the Breast After Neoadjuvant Systemic Therapy for Early Breast Cancer (MICRA trial): Interim Analysis of a Multicenter Observational Cohort Study.
Ann Surg Oncol
; 28(6): 3243-3253, 2021 Jun.
Artículo
en Inglés
| MEDLINE | ID: mdl-33263830
3.
ASO Visual Abstract: Biopsy-Guided Pathological Response Assessment in Breast Cancer is Insufficient-Additional Pathology Findings of the MICRA Trial.
Ann Surg Oncol
; 30(8): 4693-4694, 2023 Aug.
Artículo
en Inglés
| MEDLINE | ID: mdl-37160807
4.
MRI predicts pathologic complete response in HER2-positive breast cancer after neoadjuvant chemotherapy.
Breast Cancer Res Treat
; 164(1): 99-106, 2017 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-28432515
5.
Reliability of proliferation assessment by Ki-67 expression in neuroendocrine neoplasms: eyeballing or image analysis?
Neuroendocrinology
; 100(4): 288-92, 2014.
Artículo
en Inglés
| MEDLINE | ID: mdl-25342217
6.
Long-term prognosis of young breast cancer patients (≤40 years) who did not receive adjuvant systemic treatment: protocol for the PARADIGM initiative cohort study.
BMJ Open
; 7(11): e017842, 2017 Nov 14.
Artículo
en Inglés
| MEDLINE | ID: mdl-29138205
7.
Molecular diagnostics of Rickettsia africae infection in travelers returning from South Africa to The Netherlands.
Vector Borne Zoonotic Dis
; 11(12): 1541-7, 2011 Dec.
Artículo
en Inglés
| MEDLINE | ID: mdl-21867422
Resultados
1 -
7
de 7
1
Próxima >
>>